Muniyandi Jeyaraj

4.2k total citations · 2 hit papers
24 papers, 3.2k citations indexed

About

Muniyandi Jeyaraj is a scholar working on Materials Chemistry, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Muniyandi Jeyaraj has authored 24 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Materials Chemistry, 13 papers in Biomedical Engineering and 9 papers in Molecular Biology. Recurrent topics in Muniyandi Jeyaraj's work include Nanoparticles: synthesis and applications (14 papers), Graphene and Nanomaterials Applications (11 papers) and Nanoparticle-Based Drug Delivery (5 papers). Muniyandi Jeyaraj is often cited by papers focused on Nanoparticles: synthesis and applications (14 papers), Graphene and Nanomaterials Applications (11 papers) and Nanoparticle-Based Drug Delivery (5 papers). Muniyandi Jeyaraj collaborates with scholars based in South Korea, India and Ethiopia. Muniyandi Jeyaraj's co-authors include Sangiliyandi Gurunathan, Jin‐Hoi Kim, Min-Hee Kang, Muhammad Qasim, Sureshbabu Ram Kumar Pandian, Kalimuthu Kalishwaralal, Venkataraman Deepak, Soo Hyun Eom, Ramanathan Vaidyanathan and Nellaiah Hariharan and has published in prestigious journals such as The Journal of Physiology, Bioresource Technology and International Journal of Molecular Sciences.

In The Last Decade

Muniyandi Jeyaraj

24 papers receiving 3.2k citations

Hit Papers

Review of the Isolation, ... 2009 2026 2014 2020 2019 2009 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muniyandi Jeyaraj South Korea 21 1.5k 1.3k 1.1k 551 536 24 3.2k
Sumit Arora United States 35 1.7k 1.2× 1.9k 1.5× 1.1k 1.0× 902 1.6× 1.1k 2.0× 80 5.6k
Ahmed Abdal Dayem South Korea 25 1.4k 0.9× 1.2k 1.0× 1.3k 1.2× 353 0.6× 286 0.5× 58 4.1k
Debabrata Dash India 39 1.1k 0.7× 1.1k 0.8× 1.1k 1.0× 690 1.3× 180 0.3× 154 4.4k
Muhammad Qasim South Korea 25 734 0.5× 1.3k 1.0× 1.0k 0.9× 539 1.0× 561 1.0× 45 3.1k
Zhen Cao China 36 762 0.5× 1.1k 0.9× 577 0.5× 304 0.6× 427 0.8× 161 3.9k
Tae Jin Lee South Korea 31 1.4k 1.0× 636 0.5× 569 0.5× 237 0.4× 203 0.4× 187 3.5k
Lihua Hu China 37 1.3k 0.9× 1.6k 1.2× 1.2k 1.0× 185 0.3× 296 0.6× 134 4.8k
Hisham A. Alhadlaq Saudi Arabia 42 3.0k 2.0× 544 0.4× 1.6k 1.4× 828 1.5× 127 0.2× 113 5.2k
Jie Huang China 26 715 0.5× 1.0k 0.8× 539 0.5× 201 0.4× 373 0.7× 90 3.4k
Yu Fu China 29 890 0.6× 919 0.7× 1.2k 1.1× 703 1.3× 265 0.5× 102 3.6k

Countries citing papers authored by Muniyandi Jeyaraj

Since Specialization
Citations

This map shows the geographic impact of Muniyandi Jeyaraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muniyandi Jeyaraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muniyandi Jeyaraj more than expected).

Fields of papers citing papers by Muniyandi Jeyaraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muniyandi Jeyaraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muniyandi Jeyaraj. The network helps show where Muniyandi Jeyaraj may publish in the future.

Co-authorship network of co-authors of Muniyandi Jeyaraj

This figure shows the co-authorship network connecting the top 25 collaborators of Muniyandi Jeyaraj. A scholar is included among the top collaborators of Muniyandi Jeyaraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muniyandi Jeyaraj. Muniyandi Jeyaraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gurunathan, Sangiliyandi, Min-Hee Kang, Muniyandi Jeyaraj, & Jin‐Hoi Kim. (2021). Platinum Nanoparticles Enhance Exosome Release in Human Lung Epithelial Adenocarcinoma Cancer Cells (A549): Oxidative Stress and the Ceramide Pathway are Key Players. International Journal of Nanomedicine. Volume 16. 515–538. 46 indexed citations
2.
Gurunathan, Sangiliyandi, Min-Hee Kang, Muniyandi Jeyaraj, & Jin‐Hoi Kim. (2021). Palladium Nanoparticle-Induced Oxidative Stress, Endoplasmic Reticulum Stress, Apoptosis, and Immunomodulation Enhance the Biogenesis and Release of Exosome in Human Leukemia Monocytic Cells (THP-1). International Journal of Nanomedicine. Volume 16. 2849–2877. 29 indexed citations
3.
Gurunathan, Sangiliyandi, Muniyandi Jeyaraj, Min-Hee Kang, & Jin‐Hoi Kim. (2020). Anticancer Properties of Platinum Nanoparticles and Retinoic Acid: Combination Therapy for the Treatment of Human Neuroblastoma Cancer. International Journal of Molecular Sciences. 21(18). 6792–6792. 39 indexed citations
4.
Gurunathan, Sangiliyandi, Muniyandi Jeyaraj, Min-Hee Kang, & Jin‐Hoi Kim. (2020). Melatonin Enhances Palladium-Nanoparticle-Induced Cytotoxicity and Apoptosis in Human Lung Epithelial Adenocarcinoma Cells A549 and H1229. Antioxidants. 9(4). 357–357. 42 indexed citations
5.
Gurunathan, Sangiliyandi, Muniyandi Jeyaraj, Min-Hee Kang, & Jin‐Hoi Kim. (2019). Tangeretin-Assisted Platinum Nanoparticles Enhance the Apoptotic Properties of Doxorubicin: Combination Therapy for Osteosarcoma Treatment. Nanomaterials. 9(8). 1089–1089. 61 indexed citations
6.
Gurunathan, Sangiliyandi, Muniyandi Jeyaraj, Min-Hee Kang, & Jin‐Hoi Kim. (2019). The Effects of Apigenin-Biosynthesized Ultra-Small Platinum Nanoparticles on the Human Monocytic THP-1 Cell Line. Cells. 8(5). 444–444. 46 indexed citations
7.
Gurunathan, Sangiliyandi, Min-Hee Kang, Muniyandi Jeyaraj, & Jin‐Hoi Kim. (2019). Differential Immunomodulatory Effect of Graphene Oxide and Vanillin-Functionalized Graphene Oxide Nanoparticles in Human Acute Monocytic Leukemia Cell Line (THP-1). International Journal of Molecular Sciences. 20(2). 247–247. 58 indexed citations
8.
Gurunathan, Sangiliyandi, Muniyandi Jeyaraj, Min-Hee Kang, & Jin‐Hoi Kim. (2019). Graphene Oxide–Platinum Nanoparticle Nanocomposites: A Suitable Biocompatible Therapeutic Agent for Prostate Cancer. Polymers. 11(4). 733–733. 44 indexed citations
9.
Gurunathan, Sangiliyandi, Min-Hee Kang, Muniyandi Jeyaraj, & Jin‐Hoi Kim. (2019). Differential Cytotoxicity of Different Sizes of Graphene Oxide Nanoparticles in Leydig (TM3) and Sertoli (TM4) Cells. Nanomaterials. 9(2). 139–139. 66 indexed citations
10.
Jeyaraj, Muniyandi, Sangiliyandi Gurunathan, Muhammad Qasim, Min-Hee Kang, & Jin‐Hoi Kim. (2019). A Comprehensive Review on the Synthesis, Characterization, and Biomedical Application of Platinum Nanoparticles. Nanomaterials. 9(12). 1719–1719. 323 indexed citations
11.
Kim, Joon‐Chul, Sung Woo Kim, Muniyandi Jeyaraj, et al.. (2016). Shear stress activates monovalent cation channel transient receptor potential melastatin subfamily 4 in rat atrial myocytes via type 2 inositol 1,4,5‐trisphosphate receptors and Ca2+ release. The Journal of Physiology. 594(11). 2985–3004. 18 indexed citations
12.
Jeyaraj, Muniyandi, et al.. (2013). Biofabrication of gold nanoparticles and its biocompatibility in human breast adenocarcinoma cells (MCF-7). Journal of Industrial and Engineering Chemistry. 20(4). 1713–1719. 28 indexed citations
13.
Gurunathan, Sangiliyandi, Jae Woong Han, Vasuki Eppakayala, Muniyandi Jeyaraj, & Jin‐Hoi Kim. (2013). An Environmentally Friendly Approach to the Reduction of Graphene Oxide by <I>Escherichia fergusoni</I>. Journal of Nanoscience and Nanotechnology. 13(3). 2091–2098. 18 indexed citations
14.
Jeyaraj, Muniyandi, et al.. (2013). Synthesis of silver nanoparticles using pine mushroom extract: A potential antimicrobial agent against E. coli and B. subtilis. Journal of Industrial and Engineering Chemistry. 20(4). 2325–2331. 62 indexed citations
15.
Jeyaraj, Muniyandi, et al.. (2013). Antimicrobial and anticoagulation activity of silver nanoparticles synthesized from the culture supernatant of Pseudomonas aeruginosa. Journal of Industrial and Engineering Chemistry. 19(4). 1299–1303. 33 indexed citations
16.
Gurunathan, Sangiliyandi, Jae Woong Han, Vasuki Eppakayala, Muniyandi Jeyaraj, & Jin‐Hoi Kim. (2013). Cytotoxicity of Biologically Synthesized Silver Nanoparticles in MDA-MB-231 Human Breast Cancer Cells. BioMed Research International. 2013. 1–10. 308 indexed citations
17.
Gurunathan, Sangiliyandi, Kalimuthu Kalishwaralal, Ramanathan Vaidyanathan, et al.. (2009). Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli. Colloids and Surfaces B Biointerfaces. 74(1). 328–335. 628 indexed citations breakdown →
18.
Kalishwaralal, Kalimuthu, Elayappan Banumathi, Sureshbabu Ram Kumar Pandian, et al.. (2009). Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids and Surfaces B Biointerfaces. 73(1). 51–57. 202 indexed citations
19.
Pandian, Sureshbabu Ram Kumar, et al.. (2009). Synthesis of PHB nanoparticles from optimized medium utilizing dairy industrial waste using Brevibacterium casei SRKP2: A green chemistry approach. Colloids and Surfaces B Biointerfaces. 74(1). 266–273. 49 indexed citations
20.
Pandian, Sureshbabu Ram Kumar, et al.. (2009). Optimization and fed-batch production of PHB utilizing dairy waste and sea water as nutrient sources by Bacillus megaterium SRKP-3. Bioresource Technology. 101(2). 705–711. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026